La intersección de la metilación m6A y la respuesta inmune en el SOP: una perspectiva bioinformática

Área de la Ciencia:

• Endocrinology
• Molecular Biology
• Bioinformatics

Sus antecedentes:

• Polycystic ovary syndrome (PCOS) is a common endocrine disorder with unclear molecular mechanisms.
• N6-methyladenosine (m6A) RNA methylation is crucial in reproductive and endocrine functions.
• Investigating m6A genes in PCOS is essential for understanding disease pathogenesis.

Objetivo del estudio:

• To investigate key m6A RNA methylation regulators in PCOS.
• To explore the association between m6A genes and immune cell infiltration in PCOS.
• To identify potential diagnostic biomarkers and therapeutic targets for PCOS.

Principales métodos:

• Utilized public gene expression datasets (GSE137684, GSE80432, GSE114419) and clinical information.
• Analyzed m6A gene expression patterns and developed a diagnostic model using m6A gene-protein interaction networks.
• Employed GSVA and CIBERSORT for enrichment analysis and assessment of immune cell infiltration.

Principales resultados:

• Identified distinct expression patterns for m6A genes in PCOS samples.
• Established a diagnostic model highlighting WTAP, METTL14, ZC3H13, PCIF1, and RBM15.
• Found significant correlations between m6A regulators (e.g., METTL3) and immune cell levels, with METTL14, HNRNPA2B1, YTHDF3, YTHDF2, YTHDC1, and YTHDC2 as potential discriminators.

Conclusiones:

• m6A RNA methylation regulators are significantly associated with PCOS development.
• These regulators may modulate immune cell infiltration in PCOS.
• Findings suggest novel biomarkers and therapeutic strategies for PCOS.